ClinicalTrials.gg
Sign In

Spinal Cord Neoplasms clinical trials

The registry lists 105 studies for Spinal Cord Neoplasms across more than 10 countries. 27 are recruiting or about to start. 47 of them are mainly about Spinal Cord Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Spinal Cord Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
45
Recruiting
23
Status unknown
12
Terminated
11
Withdrawn
5
Not yet recruiting
4

Phase

Phase 1
19
Phase 2
17
Phase 3
5
Phase 4
2
Early Phase 1
1

Where

United States
52
China
14
Canada
8
Switzerland
6
Germany
6
United Kingdom
6

Who runs them

National Cancer Institute (NCI) (11) · Children's Oncology Group (6) · M.D. Anderson Cancer Center (5) · Peking University Third Hospital (4) · Pediatric Brain Tumor Consortium (3) · City of Hope Medical Center (3) · National Institute of Neurological Disorders and Stroke (NINDS) (3) · Beijing Tiantan Hospital (2)

What is being tested here

Drugs under test in Spinal Cord Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Temozolomide117
Remimazolam101
Pembrolizumab101
Atorvastatin101
Lisinopril101
Perillyl alcohol101
Olutasidenib101
Carboplatin005
Bevacizumab013
Vincristine003

Drug classes tested here Alkylating agents 1 open · Tyrosine kinase inhibitors (TKIs) 4 · Antimitotic agents 4

Coming up

0phase 3 studies under way
10studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 10

Who these studies take

Of the 23 Spinal Cord Neoplasms studies recruiting now, 15 (65%) set no upper age limit and 5 (22%) stop at 75 or younger. 6 (26%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (9%) take healthy volunteers.

Recruiting studies that take each age, of 23
AgeWomenMen
105 (22%)5 (22%)
1823 (100%)23 (100%)
3022 (96%)22 (96%)
4021 (91%)21 (91%)
5021 (91%)21 (91%)
6521 (91%)21 (91%)
7521 (91%)21 (91%)
8517 (74%)17 (74%)

Across all 105 studies, recruiting or not: 38% stop at 75 or younger and 33% at 65; 44% take children; 0% are for women only and 0% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Spinal Cord Neoplasms studies take

Of 21 interventional studies with no phase under Spinal Cord Neoplasms, half reached primary completion within 66 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase66 mo23–84 · 21 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 105. Browse all 105 → or search them.